-+ 0.00%
-+ 0.00%
-+ 0.00%

Intensity Therapeutics Inc. publishes clinical trial results on intratumoral INT230-6 in early-stage triple negative breast cancer

Reuters·12/18/2025 01:09:15

Please log in to view news